Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Insulin resistance, beta-cell function, adipokine profiles and cardiometabolic risk factors among Chinese youth with isolated impaired fasting glucose versus impaired glucose tolerance: the BCAMS study.

Li Y, Feng D, Esangbedo IC, Zhao Y, Han L, Zhu Y, Fu J, Li G, Wang D, Wang Y, Li M, Gao S, Willi SM.

BMJ Open Diabetes Res Care. 2020 Feb;8(1). pii: e000724. doi: 10.1136/bmjdrc-2019-000724.

2.

Evaluation of the longitudinal change in health behavior profiles across treatment groups in the TODAY clinical trial.

Kaar JL, Schmiege SJ, Drews K, Higgins J, Walders-Abramson N, Isganaitis E, Willi SM, Marcus MD, Zeitler PS, Kelsey MM.

Pediatr Diabetes. 2020 Mar;21(2):224-232. doi: 10.1111/pedi.12976. Epub 2020 Jan 6.

PMID:
31886931
3.

Integrating the Patient Health Questionnaire-2 depression screening tool into the paediatric diabetes clinic.

Gettings JM, Willi SM, Forth E, Hawkes CP.

Diabet Med. 2019 Dec;36(12):1718-1719. doi: 10.1111/dme.14146. Epub 2019 Oct 4. No abstract available.

PMID:
31557352
4.

Biologic and social factors predict incident kidney disease in type 1 diabetes: Results from the T1D exchange clinic network.

McGill JB, Wu M, Pop-Busui R, Mizokami-Stout K, Tamborlane WV, Aleppo G, Gubitosi-Klug RA, Haller MJ, Willi SM, Foster NC, Zimmerman C, Libman I, Polsky S, Rickels MR.

J Diabetes Complications. 2019 Oct;33(10):107400. doi: 10.1016/j.jdiacomp.2019.06.005. Epub 2019 Jun 26.

PMID:
31279735
5.

Poor Glycemic Control Is Associated With Impaired Bone Accrual in the Year Following a Diagnosis of Type 1 Diabetes.

Weber DR, Gordon RJ, Kelley JC, Leonard MB, Willi SM, Hatch-Stein J, Kelly A, Kosacci O, Kucheruk O, Kaafarani M, Zemel BS.

J Clin Endocrinol Metab. 2019 Oct 1;104(10):4511-4520. doi: 10.1210/jc.2019-00035.

PMID:
31034056
6.

A structured 1-year education program for children with newly diagnosed type 1 diabetes improves early glycemic control.

Hawkes CP, Willi SM, Murphy KM.

Pediatr Diabetes. 2019 Jun;20(4):460-467. doi: 10.1111/pedi.12849. Epub 2019 Apr 11.

PMID:
30932293
7.

Adipose Tissue Mediates Associations of Birth Weight with Glucose Metabolism Disorders in Children.

Wu Y, Yu X, Li Y, Li G, Cheng H, Xiao X, Mi J, Gao S, Willi SM, Li M.

Obesity (Silver Spring). 2019 May;27(5):746-755. doi: 10.1002/oby.22421. Epub 2019 Feb 27.

PMID:
30811103
8.

Circulating Osteonectin and Adipokine Profiles in Relation to Metabolically Healthy Obesity in Chinese Children: Findings From BCAMS.

Fu J, Li Y, Esangbedo IC, Li G, Feng D, Li L, Xu L, Han L, Li M, Li C, Gao S, Li M, Willi SM.

J Am Heart Assoc. 2018 Dec 4;7(23):e009169. doi: 10.1161/JAHA.118.009169.

9.

Vitamin D levels are associated with metabolic syndrome in adolescents and young adults: The BCAMS study.

Fu J, Han L, Zhao Y, Li G, Zhu Y, Li Y, Li M, Gao S, Willi SM.

Clin Nutr. 2019 Oct;38(5):2161-2167. doi: 10.1016/j.clnu.2018.08.039. Epub 2018 Sep 6.

PMID:
30236482
10.

Evaluation of ADA HbA1c criteria in the diagnosis of pre-diabetes and diabetes in a population of Chinese adolescents and young adults at high risk for diabetes: a cross-sectional study.

Li G, Han L, Wang Y, Zhao Y, Li Y, Fu J, Li M, Gao S, Willi SM.

BMJ Open. 2018 Aug 8;8(8):e020665. doi: 10.1136/bmjopen-2017-020665.

11.

Childhood retinol-binding protein 4 (RBP4) levels predicting the 10-year risk of insulin resistance and metabolic syndrome: the BCAMS study.

Li G, Esangbedo IC, Xu L, Fu J, Li L, Feng D, Han L, Xiao X, Li M, Mi J, Li M, Gao S, Willi SM.

Cardiovasc Diabetol. 2018 May 14;17(1):69. doi: 10.1186/s12933-018-0707-y.

12.

Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control.

Riddlesworth TD, Beck RW, Gal RL, Connor CG, Bergenstal RM, Lee S, Willi SM.

Diabetes Technol Ther. 2018 Apr;20(4):314-316. doi: 10.1089/dia.2017.0455. Epub 2018 Mar 22.

PMID:
29565197
13.

Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical Trial.

Bjornstad P, Nehus E, El Ghormli L, Bacha F, Libman IM, McKay S, Willi SM, Laffel L, Arslanian S, Nadeau KJ; TODAY Study Group.

Am J Kidney Dis. 2018 Jan;71(1):65-74. doi: 10.1053/j.ajkd.2017.07.015. Epub 2017 Nov 20. Erratum in: Am J Kidney Dis. 2019 Apr;73(4):580.

14.

Sleep in children with type 1 diabetes and their parents in the T1D Exchange.

Jaser SS, Foster NC, Nelson BA, Kittelsrud JM, DiMeglio LA, Quinn M, Willi SM, Simmons JH; T1D Exchange Clinic Network.

Sleep Med. 2017 Nov;39:108-115. doi: 10.1016/j.sleep.2017.07.005. Epub 2017 Jul 18.

PMID:
29157581
15.

Effect of Financial Incentives on Glucose Monitoring Adherence and Glycemic Control Among Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.

Wong CA, Miller VA, Murphy K, Small D, Ford CA, Willi SM, Feingold J, Morris A, Ha YP, Zhu J, Wang W, Patel MS.

JAMA Pediatr. 2017 Dec 1;171(12):1176-1183. doi: 10.1001/jamapediatrics.2017.3233.

16.

Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels.

Bergenstal RM, Gal RL, Connor CG, Gubitosi-Klug R, Kruger D, Olson BA, Willi SM, Aleppo G, Weinstock RS, Wood J, Rickels M, DiMeglio LA, Bethin KE, Marcovina S, Tassopoulos A, Lee S, Massaro E, Bzdick S, Ichihara B, Markmann E, McGuigan P, Woerner S, Ecker M, Beck RW; T1D Exchange Racial Differences Study Group.

Ann Intern Med. 2017 Jul 18;167(2):95-102. doi: 10.7326/M16-2596. Epub 2017 Jun 13.

PMID:
28605777
17.

Adiponectin, Insulin Sensitivity, β-Cell Function, and Racial/Ethnic Disparity in Treatment Failure Rates in TODAY.

Arslanian S, El Ghormli L, Bacha F, Caprio S, Goland R, Haymond MW, Levitsky L, Nadeau KJ, White NH, Willi SM; TODAY Study Group.

Diabetes Care. 2017 Jan;40(1):85-93. doi: 10.2337/dc16-0455. Epub 2016 Nov 1.

18.

Effects of genetic severity on glucose homeostasis in Friedreich ataxia.

Isaacs CJ, Brigatti KW, Kucheruk O, Ratcliffe S, Sciascia T, McCormack SE, Willi SM, Lynch DR.

Muscle Nerve. 2016 Nov;54(5):887-894. doi: 10.1002/mus.25136. Epub 2016 Aug 30.

19.

Novel measures of inflammation and insulin resistance are related to obesity and fitness in a diverse sample of 11-14 year olds: The HEALTHY Study.

Jago R, Drews KL, Otvos JD, Willi SM, Buse JB.

Int J Obes (Lond). 2016 Jul;40(7):1157-63. doi: 10.1038/ijo.2016.84. Epub 2016 May 4.

20.

Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial.

Gitelman SE, Gottlieb PA, Felner EI, Willi SM, Fisher LK, Moran A, Gottschalk M, Moore WV, Pinckney A, Keyes-Elstein L, Harris KM, Kanaparthi S, Phippard D, Ding L, Bluestone JA, Ehlers MR; ITN START Study Team.

Diabetologia. 2016 Jun;59(6):1153-61. doi: 10.1007/s00125-016-3917-4. Epub 2016 Apr 6.

21.

A cross-sectional view of the current state of treatment of youth with type 2 diabetes in the USA: enrollment data from the Pediatric Diabetes Consortium Type 2 Diabetes Registry.

Nambam B, Silverstein J, Cheng P, Ruedy KJ, Beck RW, Paul Wadwa R, Klingensmith G, Willi SM, Wood JR, Bacha F, Thomas IH, Tamborlane WV; Pediatric Diabetes Consortium.

Pediatr Diabetes. 2017 May;18(3):222-229. doi: 10.1111/pedi.12377. Epub 2016 Mar 11.

22.

Pregnancy Outcomes in Youth With Type 2 Diabetes: The TODAY Study Experience.

Klingensmith GJ, Pyle L, Nadeau KJ, Barbour LA, Goland RS, Willi SM, Linder B, White NH; TODAY Study Group.

Diabetes Care. 2016 Jan;39(1):122-9. doi: 10.2337/dc15-1206. Epub 2015 Dec 1.

23.
24.

Type 1 diabetes is associated with an increased risk of fracture across the life span: a population-based cohort study using The Health Improvement Network (THIN).

Weber DR, Haynes K, Leonard MB, Willi SM, Denburg MR.

Diabetes Care. 2015 Oct;38(10):1913-20. doi: 10.2337/dc15-0783. Epub 2015 Jul 27.

25.

Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.

Rigby MR, Harris KM, Pinckney A, DiMeglio LA, Rendell MS, Felner EI, Dostou JM, Gitelman SE, Griffin KJ, Tsalikian E, Gottlieb PA, Greenbaum CJ, Sherry NA, Moore WV, Monzavi R, Willi SM, Raskin P, Keyes-Elstein L, Long SA, Kanaparthi S, Lim N, Phippard D, Soppe CL, Fitzgibbon ML, McNamara J, Nepom GT, Ehlers MR.

J Clin Invest. 2015 Aug 3;125(8):3285-96. doi: 10.1172/JCI81722. Epub 2015 Jul 20.

26.

Presentation of youth with type 2 diabetes in the Pediatric Diabetes Consortium.

Klingensmith GJ, Connor CG, Ruedy KJ, Beck RW, Kollman C, Haro H, Wood JR, Lee JM, Willi SM, Cengiz E, Tamborlane WV; Pediatric Diabetes Consortium.

Pediatr Diabetes. 2016 Jun;17(4):266-73. doi: 10.1111/pedi.12281. Epub 2015 May 8.

PMID:
25951940
27.

Racial-ethnic disparities in management and outcomes among children with type 1 diabetes.

Willi SM, Miller KM, DiMeglio LA, Klingensmith GJ, Simmons JH, Tamborlane WV, Nadeau KJ, Kittelsrud JM, Huckfeldt P, Beck RW, Lipman TH; T1D Exchange Clinic Network.

Pediatrics. 2015 Mar;135(3):424-34. doi: 10.1542/peds.2014-1774.

28.

Complications and comorbidities of T2DM in adolescents: findings from the TODAY clinical trial.

Tryggestad JB, Willi SM.

J Diabetes Complications. 2015 Mar;29(2):307-12. doi: 10.1016/j.jdiacomp.2014.10.009. Epub 2014 Oct 29. Review.

29.

Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial.

Gitelman SE, Gottlieb PA, Rigby MR, Felner EI, Willi SM, Fisher LK, Moran A, Gottschalk M, Moore WV, Pinckney A, Keyes-Elstein L, Aggarwal S, Phippard D, Sayre PH, Ding L, Bluestone JA, Ehlers MR; START Study Team.

Lancet Diabetes Endocrinol. 2013 Dec;1(4):306-16. doi: 10.1016/S2213-8587(13)70065-2. Epub 2013 Aug 28.

30.

Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial.

Rigby MR, DiMeglio LA, Rendell MS, Felner EI, Dostou JM, Gitelman SE, Patel CM, Griffin KJ, Tsalikian E, Gottlieb PA, Greenbaum CJ, Sherry NA, Moore WV, Monzavi R, Willi SM, Raskin P, Moran A, Russell WE, Pinckney A, Keyes-Elstein L, Howell M, Aggarwal S, Lim N, Phippard D, Nepom GT, McNamara J, Ehlers MR; T1DAL Study Team.

Lancet Diabetes Endocrinol. 2013 Dec;1(4):284-94. doi: 10.1016/S2213-8587(13)70111-6. Epub 2013 Sep 23.

31.

Effect of relative weight group change on nuclear magnetic resonance spectroscopy derived lipoprotein particle size and concentrations among adolescents.

Jago R, Drews KL, Otvos JD, Foster GD, Marcus MD, Buse JB, Mietus-Snyder M, Willi SM; HEALTHY Study Group.

J Pediatr. 2014 May;164(5):1091-1098.e3. doi: 10.1016/j.jpeds.2013.12.029. Epub 2014 Feb 5.

32.

The association between acanthosis nigricans and dysglycemia in an ethnically diverse group of eighth grade students.

Rafalson L, Pham TH, Willi SM, Marcus M, Jessup A, Baranowski T.

Obesity (Silver Spring). 2013 Mar;21(3):E328-33. doi: 10.1002/oby.20129.

33.

Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry.

Cengiz E, Xing D, Wong JC, Wolfsdorf JI, Haymond MW, Rewers A, Shanmugham S, Tamborlane WV, Willi SM, Seiple DL, Miller KM, DuBose SN, Beck RW; T1D Exchange Clinic Network.

Pediatr Diabetes. 2013 Sep;14(6):447-54. doi: 10.1111/pedi.12030. Epub 2013 Mar 8.

34.

Low-density lipoprotein cholesterol versus particle number in middle school children.

Mietus-Snyder M, Drews KL, Otvos JD, Willi SM, Foster GD, Jago R, Buse JB; HEALTHY Study Group.

J Pediatr. 2013 Aug;163(2):355-62. doi: 10.1016/j.jpeds.2013.01.012. Epub 2013 Feb 14.

35.

Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial.

Herold KC, Gitelman SE, Willi SM, Gottlieb PA, Waldron-Lynch F, Devine L, Sherr J, Rosenthal SM, Adi S, Jalaludin MY, Michels AW, Dziura J, Bluestone JA.

Diabetologia. 2013 Feb;56(2):391-400. doi: 10.1007/s00125-012-2753-4. Epub 2012 Oct 21.

36.

A0001 in Friedreich ataxia: biochemical characterization and effects in a clinical trial.

Lynch DR, Willi SM, Wilson RB, Cotticelli MG, Brigatti KW, Deutsch EC, Kucheruk O, Shrader W, Rioux P, Miller G, Hawi A, Sciascia T.

Mov Disord. 2012 Jul;27(8):1026-33. doi: 10.1002/mds.25058. Epub 2012 Jun 28.

PMID:
22744651
37.

Cardiovascular risk factors in multi-ethnic middle school students: the HEALTHY primary prevention trial.

Willi SM, Hirst K, Jago R, Buse J, Kaufman F, El Ghormli L, Bassin S, Elliot D, Hale DE; HEALTHY Study Group.

Pediatr Obes. 2012 Jun;7(3):230-9. doi: 10.1111/j.2047-6310.2011.00042.x. Epub 2012 Mar 28.

38.

Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase.

Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Perkins BA, Welsh JB, Willi SM, Wood MA; STAR 3 Study Group.

Diabetes Care. 2011 Nov;34(11):2403-5. doi: 10.2337/dc11-1248. Epub 2011 Sep 20.

39.

Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study.

Slover RH, Welsh JB, Criego A, Weinzimer SA, Willi SM, Wood MA, Tamborlane WV.

Pediatr Diabetes. 2012 Feb;13(1):6-11. doi: 10.1111/j.1399-5448.2011.00793.x. Epub 2011 Jul 3.

PMID:
21722284
40.

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.

Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA; STAR 3 Study Group.

N Engl J Med. 2010 Jul 22;363(4):311-20. doi: 10.1056/NEJMoa1002853. Epub 2010 Jun 29. Erratum in: N Engl J Med. 2010 Sep 9;363(11):1092.

41.

The effect of insulin on expression of genes and biochemical pathways in human skeletal muscle.

Wu X, Wang J, Cui X, Maianu L, Rhees B, Rosinski J, So WV, Willi SM, Osier MV, Hill HS, Page GP, Allison DB, Martin M, Garvey WT.

Endocrine. 2007 Feb;31(1):5-17. Erratum in: Endocrine. 2007 Dec;32(3):356.

PMID:
17709892
42.

How low can we go...safely?: factors affecting intensive diabetes management.

Willi SM.

J Pediatr. 2006 Aug;149(2):154-6. No abstract available.

PMID:
16887424
43.

Atypical diabetes mellitus: time for a consensus?

Egede LE, Willi SM.

Pediatr Diabetes. 2000 Dec;1(4):226-32.

PMID:
15016220
44.

Treatment of type 2 diabetes in childhood using a very-low-calorie diet.

Willi SM, Martin K, Datko FM, Brant BP.

Diabetes Care. 2004 Feb;27(2):348-53.

PMID:
14747212
45.

Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes.

Willi SM, Planton J, Egede L, Schwarz S.

J Pediatr. 2003 Dec;143(6):796-801.

PMID:
14657831
46.
47.

Effective use of thiazolidinediones for the treatment of glucocorticoid-induced diabetes.

Willi SM, Kennedy A, Brant BP, Wallace P, Rogers NL, Garvey WT.

Diabetes Res Clin Pract. 2002 Nov;58(2):87-96.

PMID:
12213349
48.

Endogenous mutations in human uncoupling protein 3 alter its functional properties.

Brown AM, Dolan JW, Willi SM, Garvey WT, Argyropoulos G.

FEBS Lett. 1999 Dec 31;464(3):189-93.

49.

Decreased hexosamine biosynthesis in GH-deficient dwarf rat muscle. reversal with GH, but not IGF-I, therapy.

Robinson KA, Willi SM, Bingel S, Buse MG.

Am J Physiol. 1999 Mar;276(3):E435-42. doi: 10.1152/ajpendo.1999.276.3.E435.

PMID:
10070007
50.

Diabetes research in South Carolina: past, present, and future.

Willi SM, O'Rear D, Garvey WT, Colwell JA, Buse MG, Jaffa A, Lopes-Virella M, Wood D, Mayfield RK, Wallace P, Hermayer KL, Jenkins AJ, Lyons T, Mayer-Davis E.

J S C Med Assoc. 1998 Nov;94(11):502-8.

PMID:
9844316

Supplemental Content

Loading ...
Support Center